• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625358003
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/17/2018
Event Type  malfunction  
Manufacturer Narrative
Occupation is lay user/patient.This event occurred in (b)(6).
 
Event Description
The customer complained of an erroneous high inr result on coaguchek xs meter serial number (b)(4) compared to an unspecified laboratory method.At 9:00 a.M.The result from the meter was 4.3 inr.At 10:00 a.M.The result from the laboratory was 2.8 inr.The customer's therapeutic range is 2.5 - 3.5 inr.There was no allegation that an adverse event occurred.
 
Manufacturer Narrative
The customer did not return any materials for investigation.The complained test strips have been calibrated against the who standard rtf/16 and are affected by recall.Corresponding retention test strips (lot 294946) were tested in comparison to masterlot #28632180 (recalibrated lot to rtf/09).The corresponding retention material complies with the specification, based on requirements of the regular retention testing process of the qc department.The retention material and comparable masterlot test strips did not show abnormalities.Investigations have indicated results are reliable from 0.8 to 4.5 inr, since the calibration data covers this measuring range very well.Coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key8203892
MDR Text Key131772610
Report Number1823260-2018-05167
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Type of Report Initial,Followup
Report Date 03/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/31/2019
Device Catalogue Number04625358003
Device Lot Number294946
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/17/2018
Initial Date FDA Received12/28/2018
Supplement Dates Manufacturer Received12/17/2018
Supplement Dates FDA Received03/13/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALUPURINOL; DEKRISTOL - EVERY 14 DAYS; FALITHROM; METOPROLOL; SIMVASTATIN; SPIRUNULACTON; THORASEMID
Patient Age60 YR
-
-